SAB-176
Phase 2Completed 0 watching 0 views this week⚡ Active
44
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Influenza A H1N1
Conditions
Influenza A H1N1
Trial Timeline
Jun 23, 2021 → Oct 8, 2021
NCT ID
NCT04850898About SAB-176
SAB-176 is a phase 2 stage product being developed by hVIVO for Influenza A H1N1. The current trial status is completed. This product is registered under clinical trial identifier NCT04850898. Target conditions include Influenza A H1N1.
Hype Score Breakdown
Clinical
17
Activity
12
Company
2
Novelty
5
Community
5
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT04850898 | Phase 2 | Completed |
Competing Products
20 competing products in Influenza A H1N1